George Peretz has acted in many key competition cases involving and affecting the pharmaceutical industry, for the commission and General Court and European Court of Justice. He has extensive expertise and experience of advising on and litigating pharmaceutical regulatory issues. He has also represented the United kingdom government in the ECJ.

Michael is in practice at 11 South Square.  He was called to the Bar in 1980, was Treasury Junior between 1991 and 1996 when he took silk.  He has appeared in many major trade mark actions including Interflora v Marks and Spencer, Starbucks HK v Sky, Victoria Plumb v Victorian Plumbing.  He has also been a mediator for 17 years.  He has an active patent practice and recently represented the government on appeal in IPCom v Vodafone, a key decision on Crown use.  He is currently working on a number of data protection class actions in this rapidly developing jurisdiction.

Christophe Ronse leads the life sciences and patents practice at ALTIUS, and is specialized in intellectual property, with a focus on patent law and the life sciences sector. He advises and assists national and international clients in complex litigation at the Belgian level and in national and international arbitration. Christophe is a regular contributor to legal articles and a speaker at conferences mainly in the field of intellectual property & life sciences law. Together with Kirian Claeyé and Philippe de Jong, Christophe publishes the three-yearly overview of Belgian patent case law.

James Kinnaird obtained his undergraduate degree in Chemistry from Glasgow University and was awarded a PhD in organic chemistry from Cambridge University. James then followed the usual path for chemists with his background and spent time in the US doing postdoctoral work at Columbia University and then as a medicinal chemist with Pfizer, before switching track to become a patent attorney in 2005. James is currently qualified to practice in Singapore and the UK, and has passed the examinations required to represent clients before the EPO.

James is a Partner in Marks & Clerk, Singapore and has particular expertise in assisting clients with the drafting and prosecution of applications in the pharmaceutical, chemical, food, life sciences and materials fields.  James has managed and implemented strategies for protecting the inventions of pharmaceutical companies worldwide and spent a year advising a proposed, new business unit of AstraZeneca on its Freedom to Operate across multiple jurisdictions and products.

James is also heavily involved in helping pharmaceutical companies defend themselves from early entry by generic competitors into the Singapore market, as well as helping pharmaceutical companies conduct due diligence on potential acquisitions.

Matt has extensive experience of acting in large scale UK patent litigation and in multi-jurisdictional patent litigation and has acted in litigation relating to a wide range of technologies, including optics, mechanical devices, pharmaceuticals and biotechnology.

Before joining EIP, Matt worked as Senior Counsel for Teva Pharmaceuticals Europe. During his time at Teva, Matt managed high-profile litigation in the UK, Germany, France and the Netherlands, including Generics [UK] Ltd v Yeda & Teva, which related to the blockbuster drug Copaxone®.

Matt has a degree in Biochemistry from Bristol University and a PhD in Biochemistry (specialising in quantum enzymology) from Leicester University.

Qualifying in Pharmacology, Mark Engelman went on to qualify at The Bar, he also worked in-house for Dunlop Slazenger, The Body Shop and became director of Alexander McQueen, the Gucci subsidiary.  At the Bar, as an IP barrister, he acts for the likes of Apple, Inc., AstraZenaca and many others. He was appointed a Bencher to Gray’s Inn, Research Associate in IP at St. Edmunds College Cambridge and Professor at Notre Dame University.

Tim is a Partner in Osborne Clarke’s IP Disputes team in the UK. He has a particular focus on litigating patents and related rights in the pharmaceutical and biotech spaces, and has extensive experience of advising on IP strategy and enforcing and defending IP rights. He also helps clients to understand their IP risks and to exploit and monetize their IP.

Tim is ranked in the Legal 500 as a ‘next generation’ Pharma and Biotech lawyer. He is a member of EPLAW and co-chairs the Biotech litigation subcommittee of the AIPLA. He regularly speaks about IP and teaches on the subject, including on Oxford University’s Postgraduate IP Diploma.

Mark is a partner in our international Intellectual Property Group and co-head of our International Life Sciences & Healthcare Group,  based in London. He specialises in patent litigation and advise in the area of pharmaceuticals, biosimilars, biotechnology (including in food), chemicals and medical devices. His experience also extends to a diverse range of technical fields including the financial services sector. In the course of over 20 years of experience of patent litigation, Mark has been involved in devising successful litigation strategies and co-ordinating complex multi-jurisdictional disputes for clients, whilst also developing various IT solutions to improve productivity and information exchange.

Ruth Steinholtz established AretéWork in 2011 to further her mission of making a difference in the world of business ethics and by doing so to play a modest role in stopping corruption and its widespread and devastating consequences. The usual compliance focused approaches have failed to create ethical companies committed to doing the right thing and Ruth believes there is a better way, based on values.

With 20 years’ experience as a Solicitor in technology, regulatory and government affairs. Patricia has expertise in data, financial services, public sector (Health- and EdTech), and smart cities, and through her consultancy supports AI/data ethics public policy engagement, bespoke AI/data ethics governance frameworks, provides expert advisor services and curates AI/data ethics Advisory Boards.

Public speaker and writer in the field of AI and data ethics, governance, and law. Patricia sits on a number of advisory boards and committees.

Patricia Shaw is co-author of The AI Book, the Technology Governance during a Time of Crisis report, the IEEE Certification Criteria for COVID19 tracing technologies, iTechlaw’s Update to the Responsible AI Global Policy Framework, and Sweet and Maxwell’s book The Law of AI.

Sir Robin is a former Lord Justice of Appeal, having practiced at the International Property Bar from 1967. Between 1976 and 1981 he was the junior counsel for the Comptroller of Patents and for the government department in intellectual property. Sir Jacob was appointed Queen’s Counsel in 1981. He has practiced abroad often, including in Hong King, Singapore, Europe, the USA, and Australia.

Sir Jacob was appointed to the bench in 1993 and from the outset was a designated patent judge. From 1997 to 2001 he was supervising Chancery Judge for Birmingham, Bristol, and Cardiff. He was appointed as Lord Justice of Appeal in October 2003.  He continued to sit from time to time in the Court of Appeal until April 2015. He acts as an arbitrator, mediator, and expert witness on English and European law.

Michael Bowsher QC works in public procurement law as advocate, adviser and teacher – he is a Visiting Professor at King’s College, London.  His practice covers procurement, competition and commercial issues in the health sector.

He also acts as arbitrator and expert in disputes between NHS entities and has worked on a range of regulatory and trade matters involving licensing and pricing in the health sector, as well as related competition law issues.

He continues to be involved in numerous disputes over Covid-related procurement, and a range of associated issues.

His growing space law practice has also involved him global health issues and recent academic projects involve the promotion of health goals in procurement.

Greg is head of Osborne Clarke’s International Arbitration practice and a solicitor advocate. He specialises in international commercial and investment treaty arbitration, including in the life sciences sector. He also regularly sits as arbitrator and is currently a UK member of the ICC Commission on Arbitration and ADR. He is recognised as a Global Leader by Who’s Who Legal, and is described in Legal 500 as being “simply outstanding” and a “great strategist”. Greg is co-editor of the Wolters Kluwer textbook ‘Arbitration in England’ and regularly speaks on international arbitration at conferences and universities.

Sally is one of Bird & Bird’s most experienced intellectual property partners and specialises in transactional IP matters. Based in London, Sally provides the full array of commercial advice and support in IP, leading the team delivering licensing, partnering and exploitation agreements, and research, development and marketing collaborations. She advises clients on regulatory and ‘freedom to operate’ issues, and manages significant due diligence matters. Sally’s experience also extends to providing advice on the protection and exploitation of IP rights, both in stand-alone transactions and as part of acquisition, divestment or investment activity.

Rameet Sangha is a Senior Vice President at Compass Lexecon, based in London.

Rameet is a professional competition economist with over 20 years of experience advising clients on a range of competition matters: mergers, market investigations, abuse of dominance, vertical agreements, competition litigation, and damages assessment.

Rameet has experience across a range of industries, with particular expertise in life sciences and financial services.

Darach Connolly is a Senior Associate from DLA Piper Dublin office, who leads the EU and Irish competition practice in Ireland.​

Darach advises on a wide range of competition law matters in the life sciences sector including EU and national merger control, EU and Irish market investigations, cartel proceedings, distribution and licensing agreements, abuse of dominance, competition complaints and actions for damages. He also advises on EU regulatory matters, involving data protection issues, public procurement procedures and State aid rules, as well as air transport and telecommunications sector regulation.

Nicolas Pourbaix is Senior Counsel and Legal Director at AMGEN, a leading biopharmaceutical company, focusing on all areas of competition law, including pricing, supply management and parallel trade, cooperation agreements and public procurement across Europe.

In addition to anti-trust issues, Nicolas provides general legal counsel to AMGEN affiliates in a group of mid-sized European countries. Prior to joining AMGEN, Nicolas was of counsel in the anti-trust practice of the global law firm Hogan Lovells.​

Peter is a Solicitor and leading expert in Data Protection, Cyber Security regulation and Social Media Law. As Managing Director of Digital Law, he advises clients across US, Europe, Middle East and Asia. He is Chair of the Law Society’s GDPR Working Group as well as Chairing the Policy and Regulatory Affairs Committee and is a member of the Law Society Board. He is also author of the law Society Cyber Security Toolkit

A sought-after speaker, Peter presented at numerous conferences and events including the British Legal Technology Forum, the European Legal Cyber Security Forum, the London Law Expo and the Nordic Privacy Arena.

​

Gabriel is a partner in Bird & Bird’s London-based international Privacy & Data Protection practice, Gabriel advises companies on a range of international data and privacy compliance projects, including the implementation of global data management strategies, international data transfers and data compliance issues such as the General Data Protection Regulation (GDPR) or the ePrivacy directive. Gabriel has robust experience of advising clients on guarding against and mitigating potential cybersecurity intrusions and computer breach events for a broad range of major multinationals. He also regularly coordinates global notification advice for various companies who have suffered data breaches.

Stephanie is a senior associate in Bird & Bird’s Technology Transactions practice in London. She advises clients on a range of commercial matters, with a focus on the commercialisation of data and assisting clients in industries being changed by technology, or using technology as a disruptor in their industry. Stephanie has significant experience and a good understanding of the issues in these areas, having undertaken several UK and international secondments at the headquarters of some of the world’s largest companies. She has a particular interest in helping clients with the issues which arise in monetising data.

Kirian Claeyé has extensive experience in patent law and related regulatory issues, both with a particular focus on the life sciences sector. His work includes complex patent litigation, often involving cross-border issues, and on a regulatory level spans the fields of launch and marketing strategies, pricing and reimbursement, and lifecycle management of pharmaceuticals. Kirian obtained his law degree at the University of Ghent and an LL.M at the University of California, Berkeley School of Law. Kirian regularly publishes and speaks at conferences, and, together with Christophe Ronse and Philippe de Jong, Kirian publishes the three-yearly overview of Belgian patent case law.

Maria Isabel Manley leads Sidley’s Life Sciences team in London and is a distinguished thought leader and adviser on EU and UK regulatory law. She advises on a broad spectrum of matters, both contentious and non-contentious, including IP regulatory rights, market access, advertising, product liability and competition. She has represented a number of the world’s leading pharmaceutical companies in landmark cases before the EU and English Courts, as well as before the regulatory authorities, including the European Commission, the European and UK medicines authorities (EMA and MHRA), the National Institute for Health and Clinical Excellence and the Department of Health.

Marie is the co-author of “Navigating European Pharmaceutical Law,” Oxford University Press, 2015. Most recently, she has been listed in Best Lawyers 2020 for Life Sciences Law and has been awarded Best in Life Sciences at the LMG Europe Women in Business Law Award 2019.

Darren has technical expertise in a range of fields, including pharmaceuticals, agrochemicals, food chemistry, polymers, oligonucleotides, organic LEDs, semiconductors, metallurgy, batteries, and process chemistry.

He has 20 years of experience in private practice, having joined EIP from a position as Partner at the largest IP practice in the UK. Darren has considerable experience in handling difficult cases, contentious matters, and complex advisory work. He has particular experience of opposition and appeal hearings at the EPO and has advised in relation to patent litigation in the UK and other European countries. Darren also has recognised expertise in the field of registered designs.

As General Counsel, Alice Flacco oversees the global legal function of the Cardiac Rhythm Management business line of MicroPort Scientific Corporation, a multinational active in the conception, research, development and commercialization of advanced biomedical technologies and highly sensitive medical devices.

Her key functions include global responsibility for corporate governance, cross-border commercial transactions, international mergers and acquisitions, litigation, health-care regulation, intellectual property (including artificial intelligence) and anti-trust.

Prior to joining MicroPort Scientific Corporation CRM, Alice has served as an Associate lawyer for top tier international law firms including Baker McKenzie and Bird & Bird as well as global corporations in Italy, France, UK and Luxembourg where she developed a strong reputation as trusted advisor and strategic business partner.

Graduated with honors from the Law University La Sapienza in Rome and holder of two Masters including a Master 2 in Intellectual Property and Computer Science at the University of Paris II Assas, Alice is admitted to the Rome and Paris Bars.

General Counsel since 2014 for Ascension Healthcare plc, a clinical-stage pharmaceutical company focused on developing and commercialising innovative therapies for haemophilia and osteoarthritis, Justin was for ten years General Counsel at Imperial Innovations Group plc, a London listed spin-off from Imperial College London investing in biotech and industrial start-ups from leading scientific research universities.  Justin specialises in corporate finance and commercial matters mainly in the private equity and venture capital sectors. He has previously acted as General Counsel at RAC plc and prior to that was a legal adviser at GEC plc. Justin qualified as a Barrister at Lincoln’s Inn.

Will is a Partner in Osborne Clarke’s IP Disputes team and is Head of Life Sciences.  He has a focus on litigating patents, and has acted on a number of the leading UK biotech cases. Will also gives strategic patent advice to biotech companies, particularly on how to navigate third party patent estates. Will sits on the IP Advisory Committee of the UK BioIndustry Association, co-leads the BIA’s sub-committee on AI in Life Sciences, and is a tutor on Oxford University’s Postgraduate IP Diploma. Will is featured in the key legal and IP directories. Legal 500 says: “Will James stands out in life sciences litigation. He has a very bright mind, is a wonderful organiser and among the best in coordinating complex cross-border cases.“

Jacqueline’s areas of work span contract and tort. She handles commercial matters both in the UK and the US as well as personal injury, clinical negligence, insurance and product liability. Jacqueline has acted for both claimants and defendants in very high profile, public interest cases. She has acted for local authorities and insurers as well as receiving a significant volume of instructions from trades’ unions and Government departments, the Police and the Fire Brigade. She has acted for claimants in cases arising out of major disasters, including the original and recent Thalidomide claims. She is also instructed in major multi-party matters and high profile group actions against multi-national corporations. For a full copy of Jacqueline’s CV go to www. 2tg.co.uk